IMVT
Immunovant, Inc.
Key Financials
Operating Income
$-512549
N/A
Net Income
$-413840000
↓ 59.6%
Total Liabilities
$68.8M
↑ 41.5%
Total Assets
$776.2M
↑ 16.5%
Shareholders' Equity
$707.4M
↑ 14.5%
EPS (Diluted)
$-2.73
↓ 45.2%
Cash & Equivalents
$714.0M
↑ 12.4%
Operating Cash Flow
$-375874000.00
↓ 75.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IMVT |
| Company Name | Immunovant, Inc. |
| CIK | 1764013 |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| State of Incorporation | DE |
| Phone | 917-410-3120 |